Regbite Blog
FSSAI compliance insights, regulatory updates, and labelling best practices for India's nutraceutical industry.
Tagged: advertising
Nutraceuticals
The long-pending draft amendments to the Advertising and Claims Regulation are now final. Absolute claims, medical terminology and unsubstantiated health benefits are all squarely in scope — with penalties up to Rs 10 lakh per offence.